Poor-quality antimalarial drugs threaten to jeopardize progress made in malaria control over past decade
Poor-quality and fake antimalarial drugs are leading to drug resistance and inadequate treatment that is endangering global efforts made to control and eliminate malaria over the past 10 years, according to a review of the evidence published in The Lancet Infectious Diseases. In particular, the emergence of resistance to artemisinin drugs, currently the most effective treatment against malaria, on the Thailand-Cambodia border should be a wake up call, warn the authors.
Findings from the Review indicate that around 36% of antimalarial drugs analysed in southeast Asia were fake*, while a third of samples in sub-Saharan Africa failed chemical testing for containing too much or too little of the active ingredient, potentially encouraging drug resistance.
"3.3 billion people are at risk of malaria, which is endemic in 106 countries. Between 655 000 and 1.2 million people die every year from Plasmodium falciparum infection. Much of this morbidity and mortality could be avoided if drugs available to patients were efficacious, high quality, and used correctly", explains Gaurvika Nayyar from the Fogarty International Center at the National Institutes of Health (NIH) in the USA, who led the research.
Nayyar and colleagues from the NIH analysed data from published and unpublished studies that looked at chemical analyses and the packaging of antimalarial drugs in sub-Saharan Africa and southeast Asia, where the risk of contracting and dying from malaria is greatest.
Data from seven countries in southeast Asia including analysis of 1437 samples of seven malaria drugs, showed that over a third failed chemical testing, nearly half were incorrectly packaged, and about a third were fake.
Further analysis of data from 21 countries in sub-Saharan Africa including over 2500 drug samples showed similar results, with over a third failing chemical analysis and a fifth found to be fake.
Worryingly, say Nayyar and colleagues, this might only be the tip of the iceberg: "Despite a dramatic rise in reports of poor-quality antimalarial drugs over the past decade, the issue is much greater than it seems because most cases are probably unreported, reported to the wrong agencies, or kept confidential by pharmaceutical companies."
Worse still they say: "No reliable global estimates are available about the frequency of poor-quality antimalarial drugs because of no internationally accepted definitions of different types of poor-quality drugs; no globally standardised or statistically robust sampling schemes, testing protocols, and requirements for drug content; a dearth of funds; and no recognised international forum to provide technical and scientific guidance and oversight."
They conclude that several parallel interventions are needed to define and eliminate criminal production, distribution, and poor manufacturing. Their recommendations include increased investment in medicine regulatory authorities in Africa to encourage country ownership of the problem, adding that: "Currently, only three of the 47 malarious countries in Africa have laboratories that are equipped to chemically analyse antimalarial drugs."
In a linked Comment, Michael Seear from British Columbia Children's Hospital, Vancouver, Canada calls for more research to clarify the extent and cause of poor drug quality: "Drug quality is dependent on the overlapping effects of poor manufacturing standards, criminal counterfeiting, adulteration with inactive or toxic fillers, relabeling of time-expired drugs, and degradation during storage. Reliable research concerning counterfeiting is limited, and almost no information is available about the other four factors."
Moreover, he notes, the international response to the problem has been poor: "Construction of a balance between protection of intellectual property and the maintenance of drug quality has plagued the relation between WHO and the International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
Hopefully, public health will be given more priority than are intellectual property rights and WHO will develop a clearly defined and widely accepted mandate in this area."
More information: Study online: www.thelancet.com/… 4-6/abstract
Journal reference: Lancet Infectious Diseases
Provided by Lancet
- Fake malaria drugs a growing problem: experts Dec 05, 2011 | not rated yet | 0
- Fake malaria drugs threaten crisis in Africa Jan 17, 2012 | not rated yet | 0
- UN: Drug-resistant malaria spreading in Asia Nov 18, 2010 | not rated yet | 0
- Bad malaria pills in Africa raise resistance fears Feb 08, 2010 | not rated yet | 0
- Study finds early signs of malaria drug resistance in Africa Apr 27, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...
Diseases, Conditions, Syndromes 11 hours ago | not rated yet | 0
Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...
Diseases, Conditions, Syndromes 11 hours ago | 5 / 5 (1) | 0
(HealthDay)—Three-quarters of public schools in the metro Atlanta area contain microbes, including bacteria indicating the presence of fecal matter, according to research published in the May 17 issue of ...
Diseases, Conditions, Syndromes 12 hours ago | not rated yet | 0
(HealthDay)—Factors such as increased case finding may explain why Michigan had half of the total spinal infections associated with contaminated methylprednisolone acetate in the recent fungal meningitis ...
Diseases, Conditions, Syndromes 12 hours ago | not rated yet | 0
The world is unprepared for a massive virus outbreak, the deputy chief of the World Health Organization warned Tuesday, amid fears that H7N9 bird flu striking China could morph into a form that spreads easily among people.
Diseases, Conditions, Syndromes 13 hours ago | not rated yet | 0
Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...
11 minutes ago | not rated yet | 0 |
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
1 hour ago | not rated yet | 0 |
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
17 hours ago | 4.2 / 5 (5) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
15 hours ago | 4.9 / 5 (13) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
17 hours ago | 4.6 / 5 (7) | 0 |